Atara Biotherapeutics, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
116.64 |
124.02 |
52.10 |
9.30 |
81.87 |
258.48 |
| Przychód Δ r/r |
0.00% |
6.33% |
-57.99% |
-82.15% |
780.29% |
215.73% |
| Przychód (min) |
102.96 |
110.52 |
36.72 |
8.29 |
72.96 |
230.34 |
| Przychód (max) |
130.31 |
138.20 |
68.85 |
10.36 |
91.23 |
288.03 |
| EBITDA (średnia) |
-60.36 |
-64.18 |
-26.96 |
-4.81 |
-42.37 |
-133.76 |
| EBIT (średnia) |
-61.27 |
-65.15 |
-27.37 |
-4.89 |
-43.01 |
-135.79 |
| EBIT % |
-52.53% |
-52.53% |
-52.53% |
-52.53% |
-52.53% |
-52.53% |
| Zysk netto (średni) |
-15.64 |
8.96 |
-2.23 |
-18.82 |
4.49 |
77.95 |
| Zysk netto % |
-13.41% |
7.23% |
-4.28% |
-202.40% |
5.49% |
30.16% |
| EPS (średnia) |
-7.33 |
1.20 |
-0.46 |
-4.29 |
0.60 |
10.41 |
| Liczba analityków (Przychody) |
4 |
1 |
3 |
3 |
1 |
2 |
| Liczba analityków (EPS) |
4 |
2 |
2 |
2 |
1 |
1 |
| symbol |
ATRA |
ATRA |
ATRA |
ATRA |
ATRA |
ATRA |